Nonetheless, emphasizing its therapeutic implication, 6-wk continuous infusion of GLP-1(7-36NH2) at a rate of 4.8 pmol-1 kg-1 min-1 improved glycemic control and insulin sensitivity in patients with T2D (69). Here, INS is linked to type 2 diabetes mellitus.